Pasar al contenido principal

MODULACION QUIMICA DEL CODIGO DE TUBULINA COMO HERRAMIENTA PARA EL DESARROLLO Y OPTIMIZACION DE FARMACOS

PID2022-136765OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tannic Acid and Ethyl Gallate Potentialize Paclitaxel Effect on Microtubule Dynamics in Hep3B Cells

  • Sánchez-Carranza, Jessica Nayelli
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Escobar-Aguilar, Ever Angel
  • Millán-Pacheco, César
  • Álvarez, Laura
  • Salas-Vidal, Enrique
  • Díaz, José Fernando
  • González-Maya, Leticia
Among broad-spectrum anticancer agents, paclitaxel (PTX) has proven to be one of the most effective against solid tumors for which more specific treatments are lacking. However, drawbacks such as neurotoxicity and the development of resistance reduce its therapeutic efficacy. Therefore, there is a need for compounds able to improve its activity by synergizing with it or potentiating its effect, thus reducing the doses required. We investigated the interaction between PTX and tannins, other compounds with anticancer activity known to act as repressors of several proteins involved in oncological pathways. We found that both tannic acid (TA) and ethyl gallate (EG) strongly potentiate the toxicity of PTX in Hep3B cells, suggesting their utility in combination therapy. We also found that AT and EG promote tubulin polymerization and enhance the effect of PTX on tubulin, suggesting a direct interaction with tubulin. Biochemical experiments confirmed that TA, but not EG, binds tubulin and potentiates the apparent binding affinity of PTX for the tubulin binding site. Furthermore, the molecular docking of TA to tubulin suggests that TA can bind to two different sites on tubulin, one at the PTX site and the second at the interface of α and β-tubulin (cluster 2). The binding of TA to cluster 2 could explain the overstabilization in the tubulin + PTX combinatorial assay. Finally, we found that EG can inhibit PTX-induced expression of pAkt and pERK defensive protein kinases, which are involved in resistance to PXT, by limiting cell death (apoptosis) and favoring cell proliferation and cell cycle progression. Our results support that tannic acid and ethyl gallate are potential chemotherapeutic agents due to their potentiating effect on paclitaxel., This research was funded by PID2022-136765OB-I00 del Ministerio de Ciencia e Innovación de España to J. Fernando Díaz., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of potent microtubule targeting agent by structural simplification of natural diazonamide

  • Kalnins, Toms
  • Vitkovska, Viktorija
  • Kazak, Mihail
  • Zelencova-Gopejenko, Diana
  • Ozola, Melita
  • Narvaiss, Nauris
  • Makrecka-Kuka, Marina
  • Domračeva, Ilona
  • Kinens, Artis
  • Gukalova, Baiba
  • Konrad, Nele
  • Aav, Riina
  • Bonato, Francesca
  • Lucena-Agell, Daniel
  • Díaz, José Fernando
  • Liepins, Edgars
  • Suna, Edgars
74 p.-6 fig.-4 tab.-1 tab. cont.graph.-+255 p.supp.inf., The marine metabolite diazonamide A exerts low nanomolar cytotoxicity against a range of tumor cell lines; however, its highly complex molecular architecture undermines the therapeutic potential of the natural product. We demonstrate that truncation of heteroaromatic macrocycle in natural diazonamide A, combined with the replacement of the challenging-to-synthesize tetracyclic hemiaminal subunit by oxindole moiety leads to considerably less complex analogues with improved drug-like properties and nanomolar antiproliferative potency. The structurally simplified macrocycles are accessible in 12 steps from readily available indolin-2-one and tert-leucine with excellent diastereoselectivity (99:1 dr) in the key macrocyclization step. The most potent macrocycle acts as a tubulin assembly inhibitor and exerts similar effects on A2058 cell cycle progression and induction of apoptosis as does marketed microtubule-targeting agent vinorelbine., This work was supported by ERDF (Grants 1.1.1.1/16/A/281 and KC-PI-2020/16). V.V. is grateful to MikroTik Ltd. and the University of Latvia Foundation for doctoral scholarship. R.A. and N.K. thank the support from Estonian Reaserch Council (Grant PRG399) and J.F.D. acknowledges the support from Ministerio de Ciencia e Innovación (Grant PID2022-136765OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and Early Assessment of Epothilone-Derived Fluorescent Probes for Microtubule Imaging

  • Glauser, Simon
  • París-Ogáyar, Rebeca
  • Lucena-Agell, Daniel
  • Palomo, Valle
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
The synthesis of two bright epothilone-based fluorescent probes for microtubule imaging is described. Building on a tested strategy for the synthesis of epothilone-type structures, an analog of epothilone B with an extended C(6) substituent terminating in an alkyne group has been prepared. A Huisgen [3 + 2] cycloaddition of this analog with azide-functionalized derivatives of Alexa Fluor 488 and Janelia Fluor 646 gave bright fluorescent probes emitting in the green and far-red spectral range, respectively. Both probes bind to microtubules with high affinity and specifically label the microtubule network in A549 cells., Generous financial support by ETH Zurich is gratefully acknowledged (K.-H.A.). The authors acknowledge funding from the Ministerio de Ciencia e Innovación (MICIN) and FEDER (grant PID2022-136765OB-I00 to J.F.D.). V.P. acknowledges funding from Ministerio de Ciencia e Innovación and ESF for the grant RYC2019−027489-I., Peer reviewed, Sin uso de modelos vivos
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Illuminating microtubule functions with small molecules: past, present and future of fluorescent tubulin-binding probes

  • París-Ogáyar R.
  • Lucena-Agell D
  • Altmann K.-H.
  • Palomo V.
  • Díaz J.F.
Developing tools for the real-time visualization of tubulin, microtubules, and their dynamics is essential for studying key cellular processes such as cell division, migration, and differentiation. In this context, fluorescent small-molecule probes that bind to distinct and specific sites on microtubules have significantly advanced our understanding of tubulin dynamics and functions. In addition, fluorescent probes targeting tubulin have enabled the development of high-throughput screening assays to identify novel anti-tubulin compounds. In this review, we present a comprehensive overview of currently available fluorescent molecules that bind to tubulin, detailing their chemical structures, binding sites, development strategies and relevance to the study of microtubule functions. We also explore future directions in this field and highlight key fluorescent probes that are still lacking. Developing these tools would enable the investigation of tubulin's diverse cellular roles in even greater depth and support the advancement of tubulin-targeted therapeutics, This work was partially funded by grants RYC2019-027489-I (VP), PID2021-128340OA-I00 (VP) and PID2022-136765OB-I00 (JFD) from the Ministerio de Ciencia e Innovación (MICIN) and FEDER as well as CNS2022-135852 (VP) from MCIN/AEI/ 10.13039/501100011033, FSE invierte en tu futuro, and the European Union NextGenerationEU/PRTR., Peer reviewed, Sin experimentacion animal ni uso de NAMs
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An atlas of microtubule lattice parameters regulated through ligand binding to the microtubule-stabilizing sites

  • Lucena-Agell, Daniel
  • Fernández, Óscar
  • París-Ogáyar, Rebeca
  • Estévez-Gallego, Juan
  • Ondrúšková, Denisa
  • Álvarez-Bernad, Beatriz
  • Bonato, Francesca
  • Larraga, Jaime
  • Ortíz de Elguea, Diego
  • Cano, Gregorio Javier
  • Scheers, Maarten
  • Imai, Hiroshi
  • Yagi, Toshiki
  • Iwamoto, Hiroyuki
  • Carlos Martínez-Guil, Juan
  • Singh, A. Jonathan
  • Keyzers, Robert Alexander
  • Vanderwal, Christopher D.
  • Altmann, Karl-Heinz
  • Van der Eycken, Johan
  • Palomo, Valle
  • Fang, Wei-Shuo
  • Gago, Federico
  • Lánský, Zdeněk
  • Braun, Marcus
  • Oliva, María A.
  • Kamimura, Shinji
  • Díaz, José Fernando
Microtubules are dynamic cytoskeletal polymers whose lattice architecture regulates force generation, nucleotide hydrolysis, and recognition by motor proteins and microtubule-associated proteins (MAPs). Microtubule-stabilizing agents (MSAs), including taxanes and laulimalide/peloruside-site ligands, suppress depolymerization by binding to defined lattice sites, yet stabilization is not structurally neutral. How ligand chemistry reshapes lattice organization and function remains unresolved. Here, we address three mechanistic questions. First, do distinct ligand classes induce defined lattice states? Using X-ray fiber diffraction, we show that MSAs selectively stabilize two preferred longitudinal conformations, a compact state (~4.06 nm monomer rise) and an expanded state (~4.17 nm), while modulating lateral organization reflected in shifts in mean MT radius. These axial spacings cluster around discrete values across chemotypes, indicating stabilization of preexisting conformational minima rather than continuous distortion. Second, are these states interconvertible upon changes in ligand occupancy? Time-resolved diffraction reveals that longitudinal transitions occur within seconds of ligand addition even at substoichiometric occupancy, whereas, lateral equilibration proceeds slower, consistent with redistribution within heterogeneous protofilament organizations. Third, do such structural states alter nucleotide hydrolysis and motor/MAP behavior? Expanded lattices are associated with reduced apparent GTP hydrolysis rates under steady-state assembly conditions and altered kinesin motility, whereas compact lattices preferentially promote tau binding and distinct motor interaction profiles. Together, these findings establish longitudinal lattice conformation as a regulatory parameter and position MSAs as chemical tools that bias a dynamic structural landscape with predictable catalytic and transport consequences., This work was supported by the Ministerio de Ciencia e Innovación (MICIN) and FEDER (PID2022-136765OB-I00 to J.F.D. and PID2021-123399OB-I00 to M.A.O.), by the European Molecular Biology Organization (EMBO) through a Short-Term Fellowship (No. 11234 to R.P.-O.), and by MOSBRI (TNA) under project number MOSBRI-2024-296 to R.P.-O. We thank the staff of beamline BL11-NCD-SWEET at the ALBA Synchrotron (Cerdanyola del Vallès, Spain) for excellent technical support. Time-resolved kinetic experiments were performed with the approval of the SPring-8 Proposal Review Committee (proposal numbers 2016B1182, 2020A1332, and 2021A1430). We also gratefully acknowledge Ganadería Fernando Díaz for the supply of calf brains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Diferencias en la cinética y consecuencias de la evasión del punto de chequeo del huso: líneas celulares humanas versus de roedores

  • Álvarez Bernad, Beatriz
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Farmacia, leída el 17/12/2025. Esta tesis tiene embargo hasta el 17/12/2026, [EN] The cell cycle is an organized series of events that lead to the formation of two daughter cells from a mother cell. The cell cycle must be strictly regulated to ensure the correct progression of the cell, thus there are checkpoints that secure that a process does not begin if the previous one has not been successfully completed. One of the main checkpoints in the cell cycle is the spindle assembly checkpoint (SAC), which controls the metaphase-anaphase transition during cell division. The SAC remains active from the onset of mitosis, when kinetochores which are not attached to spindle microtubules inhibit the activation of the anaphase-promoting complex or cyclosome (APC/C). Once all the kinetochores of the chromosomes have bioriented on the equatorial plate, the checkpoint is satisfied, the APC/C is activated and the cohesion between sister chromatids is lost and cyclin B is degraded, licensing the anaphase. When cells are treated with antimitotic drugs, they are blocked in mitosis and can follow different fates 1) to die in mitosis or 2) to evade the SAC, a process that is called mitotic slippage. The mechanisms that allow cells to escape from a prolonged block in mitosis are currently unknown. After mitotic slippage, cells with nuclear aberrations are generated, mainly with micronuclei or restitution nuclei. These cells can undergo different fates: death, arrest in G1 or a second mitosis. Nowadays, the underlying success of treatments with antimitotic drugs in tumors with low proliferation rates is unclear. Regarding this proliferation rate paradox two explanations have been proposed: it is argued that micronuclei have a more labile nuclear envelope that collapses, triggering a signaling cascade that culminates with the activation of the immune system producing a bystander effect around the leading cell. Alternatively, it has been proposed that the success of these drugs is due to the generation of multipolar mitoses that produce incorrect chromosome segregation, generating such severe aneuploidies that they cause cell death. Cancer treatment with chemotherapy consists on the administration of antineoplasic drugs that affect the features of tumor cells. These drugs can be classified as aneugenics, which cause aneuploidy, or clastogenics, which affect DNA by different mechanisms. In this thesis, mitotic slippage is analyzed at the cytological level, being the main to study the differences in the kinetics of the mitotic slippage, the generation of multinucleated cells, and the dynamics of micronuclei, as well as the consequences such evasion; between human and rodent cell lines. To this end, cell lines of four species and three aneugenic compounds were used, two of which affect tubulin dynamics (paclitaxel and maytansine) and one that affects chromosome congression (GSK923295). The results obtained show that, with all the treatments, rodent cell lines do mitotic slippage faster than human cell lines. Regarding the compounds targeting tubulin, human, hamster and rat cell lines generate a higher percentage of micronucleated cells than mouse cell lines which generate restitution nuclei. In contrast, the drug that affects chromosome congression, which has no known effect on the microtubule cytoskeleton, generates cells with restitution nuclei in all cell lines. Rodent cell lines present a survival rate higher than human cell lines; as they also survive better after mitotic slippage, including a higher capacity to undergo and complete a second cell cycle. These findings suggest that there are clear differences in the response to antimitotic drugs between human and rodent lines, especially in the kinetics of the mitotic slippage. This observation may explain some of the discrepancies between in vitro, in vivo, and preclinical experimentation for drug approval, given that rodents, particularly mice, are the main in vivo research model. A second objective has been to evaluate whether the generation of nuclear aberrations is the common denominator among a battery of aneugenic and clastogenic compounds. Clastogenic drugs mainly cause DNA breaks, generating chromosomal fragments, and present a higher percentage of cells with restitution nuclei and a hybrid phenotype with very small micronuclei. In contrast, aneugenic compounds affect the machinery of mitosis by preventing the formation of an equatorial plate, causing chromosome missegregation, thus resulting in micronucleated cells, except for two compounds that behave more similarly to the clastogenic compounds. The results obtained indicate that both types of drugs generate nuclear aberrations, although the nature and origin of these abnormalities depend on the type of compound., [ES] El ciclo celular es un conjunto ordenado de eventos que conducen a la formación de dos células hijas a partir de una célula madre. Dicho ciclo debe estar estrictamente regulado para garantizar la correcta progresión del mismo, por ello, existen puntos de control que se aseguran que un proceso no comience si la finalización del anterior no se ha completado con éxito. Uno de los principales puntos de chequeo del ciclo celular es el punto de chequeo del huso (Spindle Assembly Checkpoint, SAC) que actúa en la mitosis controlando la transición metafase-anafase. El SAC permanece activo desde el inicio de la mitosis, momento en el cual los cinetocoros no anclados a microtúbulos (MTs) del huso inhiben la activación del complejo promotor de la anafase o ciclosoma (APC/C). Cuando todos los cinetocoros de los cromosomas han biorientado en la placa ecuatorial, el punto de chequeo se satisface, de tal forma que el APC/C se activa, y por un lado se pierde la cohesión entre cromátidas hermanas y, por otro, se degrada ciclina B licenciando la anafase. Al tratar las células con fármacos antimitóticos, el SAC no se satisface y permanece activo por lo que las células quedan bloqueadas en c-mitosis y pueden seguir diferentes destinos: 1) morir en mitosis o 2) evadir el SAC. Los mecanismos por los cuales las células escapan del bloqueo prolongado en mitosis no están claros en la actualidad. Al evadir el SAC, se generan células con aberraciones nucleares, como micronúcleos o núcleos de restitución. A su vez, estas células que evaden el SAC pueden sufrir diferentes destinos: muerte, arresto en G1 o volver a realizar una segunda mitosis. Hoy en día, el éxito subyacente al tratamiento con fármacos antimitóticos en tumores cuya tasa de proliferación es baja no está claro. Para resolver esta paradoja de la tasa de proliferación, se propone, por un lado, que los micronúcleos tienen una envoltura nuclear más lábil que colapsa desencadenando una cascada de señalización que culmina con la activación del sistema inmune lo cual afectaría también a las células vecinas. Alternativamente, se propone que el éxito de estos fármacos antimitóticos es debido a la generación de células multipolares que provocan una mala segregación de los cromosomas generando aneuploidías tan graves que llevan a la muerte de la célula. El tratamiento del cáncer mediante quimioterapia consiste en la administración de fármacos antineoplásicos que afectan a las características de las células tumorales. Estos fármacos pueden clasificarse como aneugénicos, que provocan aneuploidías, y clastogénicos, que afectan al ADN mediante distintos mecanismos En el presente trabajo, se analiza a nivel citológico la evasión del SAC, siendo el objetivo principal estudiar las diferencias en la cinética de evasión del punto de chequeo del huso, en la generación de células multinucleadas y en las consecuencias de dicha evasión; entre líneas celulares humanas versus de roedores. Para ello se han empleado líneas celulares de cuatro especies y tres compuestos aneugénicos, dos que afectan a la dinámica de tubulina (paclitaxel y maytansina), y un compuesto que afecta a la congresión cromosómica (GSK923295). Los resultados obtenidos muestran que, con cualquiera de los tres tratamientos, las líneas celulares de roedores evaden el punto de chequeo más rápido que las líneas humanas. Con los compuestos dirigidos contra tubulina, las líneas celulares humanas, de hámster y de rata, generan un mayor porcentaje de células micronucleadas que las de ratón que tienden a generar núcleos de restitución. Las líneas celulares humanas mueren más que las de roedores en el bloqueo c-mitótico, las que lo evaden vuelven a morir más que las de roedores al entrar en un nuevo ciclo, y las que sobreviven no son capaces de completar con éxito un segundo ciclo, al contrario que las de roedores que, en cada paso, muestran una supervivencia notablemente superior. Estos resultados sugieren que hay diferencias claras en el tratamiento con fármacos antimitóticos entre líneas humanas y de roedores, sobre todo en la cinética de evasión del SAC. Esta observación puede estar relacionada con las discrepancias entre la experimentación in vitro, in vivo y preclínica de fármacos antimitóticos, puesto que los roedores, principalmente ratones, son el principal modelo de investigación in vivo. Un segundo objetivo ha consistido en evaluar si la generación de aberraciones nucleares es el denominador común entre una batería de compuestos aneugénicos y clastogénicos. Los fármacos clastogénicos principalmente provocan roturas en el ADN, generando fragmentos cromosómicos, de tal forma que presentan un mayor porcentaje de células con núcleos de restitución y un fenotipo híbrido con micronúcleos de muy pequeño tamaño. Por el contrario, los aneugénicos afectan a la maquinaria de la mitosis impidiendo la formación de una placa ecuatorial de tal forma que causan una incorrecta segregación de los cromosomas originando células micronucleadas, a excepción de dos compuestos que tienen un comportamiento más similar a los clastogénicos. Los resultados obtenidos indican que ambos tipos de compuestos coinciden en generar aberraciones nucleares pero su origen y el tipo de aberración depende del tipo de compuesto, Este trabajo ha sido financiado a través de los proyectos: ID2022-136765OB-I00 y PID2019-104545RB- I00 del Ministerio de Ciencia e Innovacion. SGL2103051 de los Fondos de Recuperación Europeos y el proyecto, Bases moleculares de la regulación de microtúbulos y sus implicaciones en la neurotoxicidad producida por fármacos de la Fundación TATIANA. La doctoranda recibidó una beca FPI (PRE2020-094384) incluida en el proyecto PID2019-104545RB- I00, Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares - líneas inmortalizadas humanas, in vitro - Tipos celulares - líneas inmortalizadas animales no humanas
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Taxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling

  • Meiring, Joyce C. M.
  • Mahapatra, Varsha
  • Liu, Ruijie
  • Gravett, Molly S. C.
  • Morren, Daan
  • Saunders, Harriet A. J.
  • Choi, Sung Ryul
  • Pelster José, Andressa
  • Karhanova, Adela
  • Metallidou, Ioanna
  • Moore, Alex
  • Spoelstra, Marèl F. M.
  • Grigoriev, Ilya S.
  • Giono, Matteo
  • Iyer, Saishree S.
  • Stehbens, Samantha J.
  • Díaz, José Fernando
  • Lansky, Zdenek
  • Stecker, Kelly E
  • Steinmetz, Michel O.
  • Howes, Stuart C.
  • Kapitein, Lukas C.
  • Akhmanova, Anna
Taxanes are widely used chemotherapeutic agents that perturb cell division. They also exert effects during interphase, but the underlying mechanisms are poorly understood. Here we show that taxanes activate RhoA signalling and induce actin remodelling by releasing the RhoA activator GEF-H1 from microtubules. This taxane-induced release of GEF-H1 occurs rapidly, is independent of tubulin post-translational modifications, and can be recapitulated using purified proteins. In vitro reconstitution assays combined with analyses of microtubule structure revealed that microtubule binding by GEF-H1 is inhibited by microtubule-stabilizing ligands that expand the microtubule lattice, such as taxanes and GMPCPP, but not by others, including GTPγS and discodermolide, which stabilize a compacted microtubule lattice. Our findings demonstrate that alterations in microtubule lattice conformation can activate key signalling pathways, offering insights into the mode of action of taxanes and the possible origins of their side effects., This work was supported by the Netherlands Organization for Scientific Research (NWO) Gravitation programme IMAGINE! (project no. 24.005.009) to A.A. and L.C.K., ENW-XL grant (project no. OCENW.XL21.XL21.048) to A.A., L.C.K. and S.C.H. and the European Research Council Synergy grants PushingCell (project no. 101071793 to A.A.) and TUBULINCODE (project no. 101071583, to Z.L.), China Scholarship Council fellowship to R.L., the European Union’s Horizon Europe research and innovation programme under Marie Skłodowska-Curie grant no. 101153345 to M.S.C.G., institutional support from the CAS (RVO: 86652036, to Z.L.), the Imaging Methods Core Facility at BIOCEV supported by the MEYS CR (Large RI Project LM2018129 Czech-BioImaging, to Z.L.), ERDF (project no. CZ.02.1.01/0.0/ 0.0/16_013/0001775, to Z.L.), GAUK (project no. 204125, to Z.L.), grants from the Swiss National Science Foundation (31003A_166608 and 320030-236060; to M.O.S.), Ministerio de Ciencia e Innovación (MICIN) and Fondo Europeo de Desarrollo Regional (FEDER) grant PID2022−136765OB-I00 to J.F.D., and the Australian Research Council (DP260104604) and the Australian National Health and Medical Research Council (NHMRC 2038724) grants to S.J.S. K.E.S. is supported by the NWO-funded Netherlands Proteomics Center through the National Roadmap for Large-scale Infrastructures program XOmics (project 184.034.019). We thank the Australian Cancer Research Foundation (ACRF) for support in constructing the Institute for Molecular Bioscience Cancer Biology Imaging Facility., Peer reviewed